Showing results (261-270 of 319) with videos related to

Sort By:
Pageof 32
Journal of the American College of Cardiology|March 19, 2021
Cardiac Rehabilitation for Patients With Heart Failure: JACC Expert PanelBiykem Bozkurt, Gregg C Fonarow, Lee R Goldberg, et al.
European Journal of Heart Failure|February 15, 2017
Impaired left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: insights from the RELAX trialAdam D DeVore, Steven McNulty, Fawaz Alenezi, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 14, 2018
Digoxin use in systemic light-chain (AL) amyloidosis: contra-indicated or cautious use?Eli Muchtar, Morie A Gertz, Shaji K Kumar, et al.
ACS Applied Materials & Interfaces|June 14, 2017
Aluminate Red Phosphor in Light-Emitting Diodes: Theoretical Calculations, Charge Varieties, and High-Pressure Luminescence AnalysisNiumiao Zhang, Yi-Ting Tsai, Mu-Huai Fang, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|January 10, 2012
Core lab analysis of baseline echocardiographic studies in the STICH trial and recommendation for use of echocardiography in future clinical trialsJae K Oh, Patricia A Pellikka, Julio A Panza, et al.
Cancers|February 27, 2026
A pH-Sensitive Sprayable Fluorescent Probe Enables Accurate Visualization of Thyroid Cancer Margins for Fluorescence-Guided Surgery in Orthotopic Mouse ModelsHyungju Kwon, Javier Bravo, Ting-Chun Kuo, et al.
European Heart Journal|July 2, 2024
Secondary tricuspid regurgitation: incidence, types, and outcomes in atrial fibrillation vs. sinus rhythmJwan A Naser, Matteo Castrichini, Hossam H Ibrahim, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 18, 2023
Using a Modified Delphi Panel to Estimate Health Service Utilization for Patients with Advanced and Non-Advanced Systemic Light Chain AmyloidosisMorie Gertz, Rafat Abonour, Sarah N Gibbs, et al.
Investigational New Drugs|September 13, 2021
Phase I study of cediranib, an oral VEGFR inhibitor, in combination with selumetinib, an oral MEK inhibitor, in patients with advanced solid malignanciesJoleen M Hubbard, Jun Yin, Erin L Schenk, et al.
ESC Heart Failure|August 31, 2024
Predictors of mortality by an artificial intelligence enhanced electrocardiogram model for cardiac amyloidosisJennifer M Amadio, Martha Grogan, Eli Muchtar, et al.
Pageof 32